Alterola Biotech, Inc. (ABTI)

Alterola Biotech Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Total Valuation

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 17, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	0	4	35	173	-
Market Cap Growth	-99.90%	-87.45%	-79.62%	-	-
Enterprise Value	-	5	37	173	-
Last Close Price	0.00	0.00	0.04	0.22	-

Price Ratios

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 17, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
PB Ratio	-0.13	-3.33	3.61	15.84	-
P/OCF Ratio	-	-	-	3902.66	-

Financial Efficiency

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 17, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Debt / Equity Ratio	-1.04	-0.11	0.14	0.02	-0.10
Net Debt / Equity Ratio	-1.01	-0.11	0.14	0.02	-0.10
Quick Ratio	0.02	0.00	0.02	0.11	0.00
Current Ratio	0.32	0.00	0.02	0.12	0.00
Return on Equity (ROE)	-	-56.32%	-20.02%	-127.30%	-
Return on Assets (ROA)	-171.36%	-21.87%	-10.51%	-66.69%	-
Return on Capital Employed (ROCE)	113.30%	158.60%	-20.50%	-58.30%	40.80%

Yields

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 17, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Earnings Yield	-937.43%	-53.66%	-5.87%	-3.74%	-
Buyback Yield / Dilution	-70.86%	-30.31%	-4.82%	-	-

Data Source: S&P Global Market Intelligence Last updated: Sep 30, 2024

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 30, 2026

Data Sources Report a data error